Sanjay Chanda, Chief Development Officer at AN2 Therapeutics, Inc. (ANTX), sold 9,251 shares at $1.00 ($9K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $9k ANTX by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 3,295 | $3K | 35.4% |
| 2 | $1.01 | 5,956 | $6K | 64.6% |
| Total | $1.01 avg | 9,251 | $9K | 100% |
| Filing → |
| ANAC | SELL | 2014-12-01 | $175K | — | Filing → |
| ANAC | SELL | 2014-09-12 | $243K | — | Filing → |